Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Madhav Bhatia
University of Otago, New Zealand
Title : Hydrogen Sulfide: A Stinky Gas….. and Novel Therapeutic Target for Inflammatory Disease


Inflammation is a normal adaptive response to traumatic, infectious, post-ischemic, toxic or autoimmune injury. Uncontrolled inflammation, however, results in disease, and most of diseases have been shown to have an inflammatory component. Identifying biological molecules that mediate inflammation, and strategies that could control inflammation, therefore, can lead to novel therapeutic approaches for several diseases. Hydrogen sulfide (H2S), a toxic gas, has been known as an environmental and industrial pollutant for more than 300 years. In recent years, however, it has been shown to be produced in the human body. We have shown that H2S, synthesized by the activity of cystathionine-γ-lyase (CSE), acts as a mediator of inflammation in different disease conditions. Based on the studies with experimental models of disease, which have been substantiated by recent clinical studies, we now have a good understanding of the contribution of H2S to inflammation. Awareness of a new mediator of inflammation, which can be inhibited as a potential therapeutic approach for inflammatory disease, presents numerous opportunities. This is a new area of research with immense promise, both in terms of understanding the pathology of inflammation, and discovering new treatments for diseases which are major health problems.


Prof. Madhav Bhatia heads the Inflammation Research Group in the Department of Pathology and Biomedical Science at the University of Otago, Christchurch. Research in his laboratory has shown hydrogen sulfide and substance P as mediators of inflammation and potential therapeutic targets for inflammatory diseases such as acute pancreatitis, sepsis, burn injuries, and joint inflammation. He has received numerous grants, has authored more than 180 contributions to the peer-reviewed literature, given several invited presentations in different countries and is on Editorial Boards of 42 journals. His publications have been cited more than 11000 times, and he has an "h"-index of 56.”